Qcil’s Artemether/Lumefantrine 20mg/120mg tablet prequalified by World Health Organization.
Released On August 27, 2026
WHO prequalifies Qcil’s Artemether/Lumefantrine 20 mg/120 mg tablet
Latest Media Releases
Qcil and Medicines Patent Pool Sign Sublicense to Expand Access to Influenza Treatment
25 September 2026
Qcil and Medicines Patent Pool Sign Sublicense to Expand Access to Influenza Treatment
Qcil Enters Agreement with MSD to Expand Future Access to Alimatravir in Africa
24 July 2026
Qcil Enters Agreement with MSD to Expand Future Access to Alimatravir in Africa
PulseNews: Nigeria Delegation Explores Pharmaceutical Market Access at Qcil
11 September 2026
A Nigerian delegation has visited Quality Chemical Industries Limited (QCIL) in Luzira, Kampala, to explore opportunities for expanding Uganda's pharmaceutical exports into the Nigerian market as the two countries deepen trade and investment cooperation.
Qcil Delivers Record FY26 Performance, Advances Africa-Centric Growth Strategy
30 June 2026
Qcil Delivers Record FY26 Performance, Advances Africa-Centric Growth Strategy
Quality Chemical Industries Limited (Qcil) Launches Hydroxyurea Treatment to Improve Care for Sickle Cell Disease Patients
20 May 2026
Quality Chemical Industries Limited (Qcil) Launches Hydroxyurea Treatment to Improve Care for Sickle Cell Disease Patients